SCHEMBL25951483

SCHEMBL25951483

Cc1ccc(S(=O)(=O)N/N=C/[C@H]2OC(n3ccc4c(Cl)ncnc43)[C@@H]3OC(C)(C)O[C@H]23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.38
▸ TDP1 Q9NUW8 2/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ PRMT5 O14744 10/20 0.36
▸ WDR77 Q9BQA1 10/20 0.36
▸ ALDH1A1 P00352 6/20 0.33
▸ RECQL P46063 2/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18572275 1.00 KMT2A (0.38) KMT2ATDP1MEN1MAPTNPC1
SCHEMBL18571963 0.87 RXFP1 (0.37) KMT2ATDP1MEN1MAPTNPC1
SCHEMBL22002061 0.83 KMT2A (0.36) KMT2ATDP1MEN1MAPTNPC1
SCHEMBL18571954 0.83 KMT2A (0.36) KMT2ATDP1MEN1MAPTNPC1
SCHEMBL18572278 0.80 ALDH1A1 (0.33) KMT2ATDP1MEN1MAPTNPC1
SCHEMBL18571918 0.79 PRMT5 (0.42) PRMT5WDR77RAPGEF3
SCHEMBL25951474 0.77 KMT2A (0.37) KMT2ATDP1MEN1MAPTNPC1
SCHEMBL21089769 0.77 PRMT5 (0.40) PRMT5WDR77
SCHEMBL22683096 0.76 RXFP1 (0.49) PRMT5WDR77RXFP1RAPGEF3
SCHEMBL18572012 0.76 RXFP1 (0.49) PRMT5WDR77RXFP1RAPGEF3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4219496-A1 NOVEL 6-6 BICYCLIC AROMATIC RING SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS JANSSEN Pharmaceutica NV (BE) 2023-08-02 — — EP disclosed
Send feedback